Plecanatide & Linaclotide are two drugs made by two different companies but both target Irritable Bowel Syndrome in a similar way.

Plecanatide is being developed by Synergy Pharmaceuticals while Linaclotide is being developed by Ironwood Pharmaceuticals. These drugs are targeted towards those with constipation predominant IBS with associated IBS related abdominal pain. Continue reading “Plecanatide & Linaclotide, Similar Experimental Treatments For IBS” »

For Now, FDA Blocks Approval Of Xifaxan for Usage By Those With Irritable Bowel Syndrome.

Salix Pharmaceuticals confirmed on Tuesday(March 8th, 2011) that approval of their drug Xifaxan(aka Rifaxamin) for use in those with Irritable Bowel Syndrome was put on hold by the FDA for the time being. The FDA stated that they did not feel the drug was ready for approval in it’s current form & are requesting Salix provide them with additional information about the drug before they’ll reconsider. Salix’s stock price took an immediate hit on the news & has stayed down by about 25% since. Continue reading “FDA Puts Brakes On Approval Of Salix’s Xifaxan For Irritable Bowel Syndrome” »

Copyright © 2024 The Digestion Blog - Mark & Gabriel Hedges.

Privacy Policy